News Column

Vigil Health Solutions Reports Revenue/Bookings Growth Resulting in Profitable Quarter and Year to Date Results

Page 2 of 3

Detailed financial statements along with Management Discussion and Analysis have been filed with SEDAR (www.sedar.com).

Financial information will be mailed to entitled security holders on February 22, 2013. Or, upon notice to the Company, entitled security holders may request a copy of financials in advance.

Summary Financial Information

--------------------------------------------------------------------------------------------------------------------------------------------------------                                              December 31,     December 31,                                                      2012             2011                                               (unaudited)      (unaudited)----------------------------------------------------------------------------Revenue                                      $   1,096,167    $     786,737Cost of sales                                      546,081          420,835----------------------------------------------------------------------------                                                   550,086          365,902Expenses                                           424,482          451,894----------------------------------------------------------------------------Income (loss) before the following items           125,604          (85,992)Other income (expense):                              6,099           18,167----------------------------------------------------------------------------Income / (loss) for the period               $     131,703    $     (67,825)--------------------------------------------------------------------------------------------------------------------------------------------------------


Non-IFRS Measure

For the three months ended December 31, 2012, we are disclosing Adjusted EBITDA, a non-IFRS financial measure, as a supplementary indicator of operating performance. We define Adjusted EBITDA as net income before, interest, income taxes, amortization, stock based compensation and currency gains or losses including derivative foreign exchange differences. We are presenting the non-IFRS financial measure in our filings because we use it internally to make strategic decisions, forecast future results and to evaluate our performance and because we believe that our current and potential investors and analysts use the measure to assess current and future operating results and to make investment decisions. It is a non-IFRS measure, may not be comparable to other companies and it is not intended as a substitute for IFRS measures.

Adjusted EBITDA Reconciliation

--------------------------------------------------------------------------------------------------------------------------------------------------------                         Three months ended           Nine months ended                      December 31, December 31,   December 31, December 31,                              2012         2011           2012         2011----------------------------------------------------------------------------Income / (loss) for the period          $     131,703      (67,825)       102,570     (374,676)Add / (deduct)  Foreign exchange          (9,970)      14,168        (16,731)      (9,902)  Derivative   exchange                     79      (34,337)         5,721       (5,287)  Interest                   3,792        2,002         11,977       12,129  Stock based   compensation             13,458        1,529         26,812        6,030  Amortization               3,814        5,245         12,043       17,759----------------------------------------------------------------------------                            11,173      (11,393)        39,822       21,429----------------------------------------------------------------------------Adjusted EBITDA      $     142,876      (79,218)       142,393     (353,247)--------------------------------------------------------------------------------------------------------------------------------------------------------

Continued | 1 | 2 | 3 | Next >>

Story Tools